| Literature DB >> 27760233 |
Yu-Hui Peng1, Ching-Houng Lin1, Chao-Nan Lin2, Chen-Yu Lo1, Tsung-Lin Tsai1, Hung-Yi Wu1.
Abstract
Similar to eukaryotic mRNA, the positive-strand coronavirus genome of ~30 kilobases is 5'-capped and 3'-polyadenylated. It has been demonstrated that the length of the coronaviral poly(A) tail is not static but regulated during infection; however, little is known regarding the factors involved in coronaviral polyadenylation and its regulation. Here, we show that during infection, the level of coronavirus poly(A) tail lengthening depends on the initial length upon infection and that the minimum length to initiate lengthening may lie between 5 and 9 nucleotides. By mutagenesis analysis, it was found that (i) the hexamer AGUAAA and poly(A) tail are two important elements responsible for synthesis of the coronavirus poly(A) tail and may function in concert to accomplish polyadenylation and (ii) the function of the hexamer AGUAAA in coronaviral polyadenylation is position dependent. Based on these findings, we propose a process for how the coronaviral poly(A) tail is synthesized and undergoes variation. Our results provide the first genetic evidence to gain insight into coronaviral polyadenylation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27760233 PMCID: PMC5070815 DOI: 10.1371/journal.pone.0165077
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Determination of the minimum poly(A) tail length for the initiation of poly(A) tail lengthening.
(A) DI RNA constructs with various poly(A) tail lengths. (B) Poly(A) tail lengths for DI RNA constructs at different times, as determined by sequencing the RT-PCR products shown in S2 Fig. Input: DI RNA transcript used for transfection, as shown in Fig 1A.
Fig 2Effect of hexamer AGUAAA on polyadenylation of DI RNA with 25 nts of poly(A) tail.
(A) DI RNA constructs with 25 nts of poly(A) tail in which hexamer AGUAAA was substituted with UCAUUU (R-25A) or maintained (W-25A). (B) lengths of R-25A and W-25A poly(A) tails at 24 hpi of VP1. (C) Stability of R-25A and W-25A in uninfected cells as measured by Northern blot assay. Transcripts were transfected and RNA was extracted at the times indicated. The amount of each DI RNA at 24 hpt was quantitated and compared with that at 1 hpt. (D) Left panel: the amounts of DI RNAs R-25A and W-25A at 24 hpi of VP1 as measured by Northern blot assay with BCoV N subgenomic mRNA (sgm RNA) and 18S rRNA as internal controls. Right panel: quantitation of the relative efficiency of replication between R-25A and W-25A. (E) Detection of potential recombination between DI RNA and BCoV genome at 24 hpi of VP1. The primer MHV3’UTR2(+), which anneals to the 3’ UTR of DI RNA and primer BM3(-),which anneals to the BCoV M protein gene were used for RT-PCR to identify the potential recombination between BCoV genome and R-25A (lane 2) or W-25A (lane 3). The recombinant DNA of 1,639 nts between DI RNA and BCoV genome shown in lane 4 was produced by overlap PCR and used as a size marker. Lane 1: ds DNA size markers. (F) Upper panel: DI RNA constructs R(C)-25A and W(C)-25A in which the nt at the position 2 upstream of poly(A) tail in DI RNAs R-25A and W-25A was mutated from A to C, respectively. Lower panel: sequence of the 3’ end of DI RNA at 24 hpi of VP1; the nt C at the position 2 upstream of poly(A) tail is given at the bottom of the sequence.
Fig 3Effect of hexamer AGUAAA and poly(A) tail length on polyadenylation of DI RNA.
(A) DI RNA constructs with various poly(A) tail lengths in which hexamer AGUAAA was substituted with UCAUUU (left panel) or maintained (right panel). (B) RT-PCR products synthesized using the method described in S1C Fig RNA samples were collected at 24 hpi of VP1 from cells treated with the supernatant from DI RNA-transfected BCoV-infected cells (left panel) or from DI RNA-transfected mock-infected cells (right panel). For uncropped gel images, see S3 Fig. (C) DI RNA poly(A) tail lengths, as determined by sequencing analysis of the RT-PCR products shown in Fig 3B. (D) Stability of DI RNA variants in uninfected cells as measured by Northern blot assay. The amount of each DI RNA at the times indicated was quantitated and compared with that at 1 hpt. (E) The amounts of DI RNA variants at 24 hpi of VP1 as measured by Northern blot assay. (F) Detection of potential recombination between DI RNAs W-25A (lane 2), R-5A (lane 3), R-15A (lane 4) or R-20A (lane 5) and BCoV genome. The recombinant DNA of 1,639 nts between DI RNA and BCoV genome shown in lane 6 was produced by overlap PCR and used as a size marker. Lane 1: ds DNA size markers.
Fig 4Synthesis of a poly(A) tail from poly(A) tail-lacking DI RNA.
(A) Left panel: hexamer AGUAAA-containing DI RNA constructs with a poly(A) tail or other non-poly(A) sequences immediately downstream of the 3’UTR. Right panel: sequences of the 3’ end of DI RNA at the indicated times. (B) Left panel: hexamer AGUAAA-deficient DI RNA constructs with a poly(A) tail or other non-poly(A) sequences immediately downstream of the 3’UTR. Right panel: sequence of the 3’ end of DI RNA at 24 hpi of VP1. N/A: not available.
Fig 5Dissection of hexamer AGUAAA to characterize its role in coronaviral polyadenylation.
(A) DI RNA constructs with a series of mutations within hexamer AGUAAA and with a poly(A) tail of 15 (left panel) or 25 (right panel) nts in length. The mutated sequence is underlined. (B) RT-PCR products synthesized using the method described in Fig; RNA samples were harvested at 24 hpi of VP1. (C) The poly(A) tail length, as determined by sequencing the RT-PCR products shown in Fig 5B.
Fig 6The function of hexamer AGUAAA in coronaviral polyadenylation is position dependent.
(A) Upper panel: sequence within the 3’-terminal 60 nts of DI RNA. The number above the sequence indicates the position of nt counted from poly(A) tail. Lower panel: DI RNA constructs with a poly(A) tail of 15 (left panel) or 25 (right panel) nts in length, wherein the sequence (underlined) was mutated at position 37–42 (from hexamer AGUAAA to UCAUUU) and/or at position 49–54 (from CUGCAA to hexamer AGUAAA). (B) RT-PCR products synthesized from the method described in S1C Fig; RNA samples were collected at 24 hpi of VP1. (C) The poly(A) tail length, as determined by sequencing of the RT-PCR products shown in Fig 6B.
Postulated poly(A) signal in coronaviruses.
| Virus | Sequences | Position | GenBank accession no. |
|---|---|---|---|
| TGEV-Purdue | UGUAAA | 39–34 | DQ811788 |
| FCoV | UGUAAA | 39–34 | NC_002306 |
| HCoV-229E | AGUAAC | 37–32 | NC_002645 |
| ScBtCoV-512 | AGUAAC | 36–31 | NC_009657 |
| PEDV | AGUAAC | 37–32 | NC_003436 |
| MiBtCiV-HKU8 | AGUAAU | 38–33 | NC_010438 |
| BCoV-Mebus | AGUAAA | 42–37 | U00735 |
| HCoV-OC43 | AGUAAA | 42–37 | NC_005147 |
| PHEV-VW572 | AGUAAA | 42–37 | NC_007732 |
| ECoV | AGUAAA | 42–37 | NC_010327 |
| MHV-A59 | AGUAAA | 42–37 | NC_001846 |
| MHV-JHM | AGUAAA | 42–37 | NC_006852 |
| RbCoV-HKU14 | AGUAAA | 42–37 | NC_017083 |
| SARS-CoV-Tor2 | AAUUAA | 57–52 | NC_004718 |
| BtSARS-CoV-Rp3 | AAUUAA | 57–52 | DQ071615 |
| BtSARS-CoV-HKU3 | AAUUAA | 57–52 | DQ022305 |
| BtCoV-133/2005 | AAUAAA | 49–44 | NC_008315 |
| PiBTCoV-HKU5 | AAUAAA | 49–44 | NC_009020 |
| MERS-CoV | AAUAAA | 49–44 | NC_019843 |
| RoBtCoV-HKU9 | AUUAUA | 55–50 | NC_009021 |
| IBV-Beaudette | AGUUAA | 34–29 | NC_001451 |
| TCoV | AGUUAA | 34–29 | NC_010800 |
| PorCoV-HKU15 | AUUAAA | 29–24 | NC_016990 |
| SpCoV-HKU17 | AUUAAA | 29–24 | NC_016882 |
| MunCoV-HKU13 | AUUAAA | 29–24 | NC_011550 |
| MRCoV-HKU18 | AUUAAA | 29–24 | NC_016993 |
| BuCoV-HKU11 | AUUAAA | 29–24 | FJ376619 |
a. TGEV-Purdue, porcine transmissible gastroenteritis virus Purdue strain; FCoV, feline infectious peritonitis virus; RhBtCoV-HKU2, Rhinolophus bat coronavirus HKU2; HCoV-NL63, human coronavirus NL63; HCoV-229E, human coronavirus 229E; SCBtCoV-512, Scotophylus bat coronavirus; PEDV, porcine epidemic diarrhea virus; MiBtCoV-HKU8, bat coronavirus HKU8; BCoV-Mebus, bovine coronavirus strain Mebus; HCoV-OC43, human coronavirus OC43; PHEV-VW572, porcine hemagglutinating encephalomyelitis virus; ECoV, equine coronavirus; MHV-A59, mouse hepatitis virus strain A59; MHV-JHM, mouse hepatitis virus strain JHM; RbCoV-HKU14, rabbit coronavirus HKU14; SARS-CoV-Tor2, SARS coronavirus isolateTor2; BtSARS-CoV-Rp3, bat SARS coronavirus Rp3; BtSARS-CoV-HKU3, bat SARS coronavirus HKU3; BtCoV-133/2005, bat coronavirus 133/2005; PiBTCoV-HKU5, Pipistrellus bat coronavirus HKU5; MERS-CoV, Middle East respiratory syndrome coronavirus or human betacoronavirus 2c EMC/2012; BtCoV-HKU9, bat coronavirus HKU9; IBV-Beaudette, avian infectious bronchitis virus strain Beaudette; TCoV, turkey coronavirus; PorCoV-HKU15, porcine coronavirus HKU15 strain HKU15-44; SpCoV-HKU17, sparrow coronavirus HKU17; MunCoV-HKU13, munia coronavirus HKU13-3514; MRCoV-HKU18, magpie-robin coronavirus HKU18; BuCoV-HKU11, bulbul coronavirus HKU11-934.
b. The number indicates the nucleotide position counted from ploy(A) tail.
Fig 7The proposed mechanism for polyadenylation in coronaviruses.
Coronavirus replication complex utilizes positive-strand viral RNA as a template to synthesize negative-strand viral RNA with a poly(U) tract. The nascent negative-strand RNA in turn serves as a template for synthesizing positive-strand RNA. After hexamer AGUAAA on the positive-strand RNA is copied, binding of related proteins to the motif on the positive strand and that of polyadenylation-related proteins to the poly(U) tract on the negative strand along with coronavirus RNA-dependent RNA polymerase (RdRp) or cytoplasmic poly(A) polymerase (PAP) form a polyadenylation complex for poly(A) tail synthesis.